109
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Gd-DTPA in Male Urethrography

A case report

&
Pages 804-805 | Accepted 14 Dec 1995, Published online: 07 Jan 2010

References

  • Bloem J. L., Wondergem J. Gd-DTPA as a contrast agent in CT. Radiology 1989; 171: 578
  • Gibson R. J., Meanock C. I., Torrie E. P. H., Walker T. M. An assessment of Gd-DTPA as a CT contrast agent in the renal tract. Clin. Radiol. 1993; 47: 278
  • Janon E. A. Gadolinium-DPTA. A radiographic contrast agent. AJR 1989; 152: 1348
  • Katayama H., Yamaguchi K., Kozuka T., Takashima T., Seez P., Matsuura K. Adverse reactions to ionic and nonionic contrast media. The report from the Japanese Committee on the Safety of Contrast Media. Radiology 1990; 175: 621
  • Kinno Y., Odagiri K., Itoh Y., Tarao K. Gadopentetate dimeglumine as an alternative contrast material for use in angiography. AJR 1993; 160: 1293
  • Niendorf H. P., Alhassan A., Balzer T., Clauss W., Cornelius I. Safety and risk of gadolinium-DTPA. Extended clinical experience after more than 5000000 applications. Magnevist®, monograph, R. Felix, et al. Blackwell Scientific Publications, Oxford 1994; 21
  • Quinn A. D., O'Hare N. J., Wallis F. J., Wilson G. F. Gd-DTPA. An alternative contrast medium for CT. J. Comput. Assist. Tomogr. 1994; 18: 634
  • Schild H. H., Weber W., Boeck E., et al. Gadolinium-DTPA (Magnevist®) als Kontrastmittel für die arterielle DSA. RöFO 1994; 160: 218

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.